Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment‐naïve patients: A single‐center study-Reference-Cited by-同舟云学术

Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment‐naïve patients: A single‐center study

Published:2022-02-25 Issue:11 Volume:11 Page:2193-2203
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Nikas Ilias P.¹^ORCID,Lee Cheol²,Song Min Ji³,Kim Bohyun²,Ryu Han Suk²³⁴^ORCID

Affiliation:

1. School of Medicine, European University Cyprus Nicosia Cyprus

2. Department of Pathology, Seoul National University Hospital Seoul Republic of Korea

3. Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital Seoul Republic of Korea

4. Department of Pathology, Seoul National University College of Medicine Seoul Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4600

Reference60 articles.

1. Cancer Statistics, 2021

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice Guidelines

4. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

5. Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer;Ramalingam P;Oncology,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of EGFR, PD‐L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high‐grade serous tubo‐ovarian carcinoma;Diagnostic Cytopathology;2023-11-08

2. Discrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers;Pathobiology;2023-10-10

3. The correlation of PD-L1 expression in cytological and histological material of serous high-grade ovarian cancer;Srpski medicinski casopis Lekarske komore;2023

4. A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer;Cancers;2022-09-01

5. PD‐L1 immunohistochemical testing: A review with reference to cytology specimens;Diagnostic Cytopathology;2022-08-20